Anib Tablet 40 mg contains Afatinib Dimaleate, a targeted cancer therapy classified as a tyrosine kinase inhibitor (TKI). It is primarily used for the treatment of non-small cell lung cancer (NSCLC) that is positive for specific epidermal growth factor receptor (EGFR) mutations. By blocking EGFR signaling pathways, Afatinib helps slow the growth and spread of cancer cells.

Anib Tablet offers an oral, once-daily therapy option for patients with advanced or metastatic NSCLC. It is particularly beneficial for individuals whose tumors are driven by EGFR mutations, providing a personalized treatment approach that targets the molecular drivers of cancer.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

How It Works

Afatinib Dimaleate works by irreversibly inhibiting the activity of EGFR (ErbB1), HER2 (ErbB2), and HER4 (ErbB4), which are proteins involved in cell growth and proliferation. By blocking these receptors:

• Cancer cell signaling is disrupted, reducing tumor growth

• Proliferation of abnormal cells slows down

• Tumor progression is delayed, and symptom control is improved

• Targeted therapy minimizes damage to healthy cells compared to traditional chemotherapy

This mechanism makes Anib a precision therapy for patients with EGFR-mutated NSCLC, improving progression-free survival and quality of life.

Indications

Anib Tablet 40 mg is indicated for:

• First-line treatment of advanced or metastatic NSCLC with EGFR mutations

• Patients with tumors harboring specific activating EGFR mutations (e.g., exon 19 deletions, exon 21 L858R substitution)

• Targeted therapy in patients who may not tolerate standard chemotherapy

The tablet is prescribed under strict medical supervision with confirmation of EGFR mutation status.

Dosage and Administration

• The recommended dose is 40 mg orally once daily, taken at the same time each day.

• Swallow the tablet whole with a glass of water; do not crush, chew, or split.

• Take on an empty stomach or at least 1 hour before or 2 hours after a meal for optimal absorption.

• Dose adjustments may be required in case of adverse effects, liver or kidney impairment, or drug interactions.

Patients are advised to maintain consistent daily dosing and report any unusual side effects promptly.

Benefits of Anib Tablet

• Targets EGFR-mutated NSCLC effectively

• Slows tumor progression and growth

• Oral administration allows convenient home therapy

• Minimizes exposure to healthy cells compared to conventional chemotherapy

• Improves patient outcomes and quality of life in advanced lung cancer

Possible Side Effects

Common side effects of Anib Tablet may include:

• Diarrhea

• Rash, acne-like skin eruptions

• Mouth sores (stomatitis)

• Nausea and vomiting

• Fatigue

Serious but less common side effects include liver toxicity, lung inflammation (interstitial lung disease), and severe diarrhea. Patients should report any persistent or severe symptoms immediately.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Precautions and Warnings

• Confirm EGFR mutation status before initiating therapy.

• Regular monitoring of liver function, kidney function, and clinical symptoms is required.

• Use cautiously in patients with pre-existing lung disease or cardiac conditions.

• Avoid pregnancy; effective contraception is mandatory for both male and female patients during treatment.

• Inform your doctor about all medications to prevent harmful drug interactions.

Storage Instructions

Store below 30°C in a cool, dry place, away from light and moisture. Keep out of reach of children.

Anib Tablet 40 mg (Afatinib Dimaleate) provides an effective targeted therapy option for patients with EGFR-positive non-small cell lung cancer, offering improved disease control and quality of life under careful medical supervision.